Contrary to the strategy adopted by the United Kingdom, Spain is expected to maintain its plan to administer two doses per person of the COVID-19 vaccine tozinameran, which is the recommendation of the manufacturer Pfizer-BioNTech. Germany is also considering the single-dose strategy.
Contrary to the strategy adopted by the United Kingdom, Spain is expected to maintain the plan to administer two doses per person of the COVID-19 vaccine Tozinameran, which is the recommendation of the manufacturer Pfizer-BioNTech. Germany is also considering the single-dose strategy.
Contrary to the strategy adopted by the United Kingdom, Spain is expected to maintain their plan to administer two doses per person of the COVID-19 vaccine Tozinameran, which is the recommendation of the manufacturer Pfizer-BioNTech. Germany is also considering the single-dose strategy.
Contrary to the strategy adopted by the United Kingdom, Spain is expected to maintain its plan to administer two doses per person of the COVID-19 vaccine tozinameran, which is the recommendation of the manufacturer Pfizer-BioNTech. Germany is also considering the single-dose strategy.
